# Intuitive Machines, Inc.: financial statements, quarterly

LUNR · Nasdaq · CIK 1844452 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lunr.md) · [Financials](/companies/lunr/financials.md) · [Filings](/companies/lunr/filings.md) · [Insiders](/companies/lunr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lunr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.7](/filings/0001844452-24-000132.md) | [30.6 d](/filings/0001844452-25-000023.md) | [73.2](/filings/0001844452-25-000043.md) | [41.6](/filings/0001844452-25-000054.md) | [58.5](/filings/0001628280-25-052039.md) | [54.7 d](/filings/0001628280-26-019865.md) | [62.5](/filings/0001628280-26-035236.md) | [50.3](/filings/0001628280-26-056821.md) | [51.0](/filings/0001628280-25-052039.md) | [43.3 d](/filings/0001628280-26-019865.md) | [184](/filings/0001628280-26-035236.md) | [203](/filings/0001628280-26-056821.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0001628280-26-035236.md) | [0.5](/filings/0001628280-26-056821.md) | not reported | not reported | [5.6](/filings/0001628280-26-035236.md) | [7.7](/filings/0001628280-26-056821.md) |
| Operating income | $m | [(24.0)](/filings/0001844452-25-000023.md) | [(7.5) d](/filings/0001844452-25-000023.md) | [(2.8)](/filings/0001844452-25-000043.md) | [(27.5)](/filings/0001844452-25-000054.md) | [(13.7)](/filings/0001628280-25-052039.md) | [(13.4) d](/filings/0001628280-26-019865.md) | [(10.1)](/filings/0001628280-26-035236.md) | [(28.6)](/filings/0001628280-26-056821.md) | [(15.4)](/filings/0001628280-25-052039.md) | [(33.1) d](/filings/0001628280-26-019865.md) | [(39.2)](/filings/0001628280-26-035236.md) | [(47.1)](/filings/0001628280-26-056821.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-25-052039.md) | [0.0 d](/filings/0001628280-26-019865.md) | [0.0](/filings/0001628280-26-035236.md) | [0.1](/filings/0001628280-26-056821.md) | [1.3](/filings/0001628280-25-052039.md) | [2.7 d](/filings/0001628280-26-019865.md) | [4.9](/filings/0001628280-26-035236.md) | [4.5](/filings/0001628280-26-056821.md) |
| Income tax | $m | [0.6](/filings/0001844452-24-000132.md) | [(0.3) d](/filings/0001844452-25-000023.md) | [0.0](/filings/0001844452-25-000043.md) | [0.0](/filings/0001844452-25-000054.md) | [0.1](/filings/0001628280-25-052039.md) | [(0.0) d](/filings/0001628280-26-019865.md) | [0.0](/filings/0001628280-26-035236.md) | [0.0](/filings/0001628280-26-056821.md) | [0.0](/filings/0001628280-25-052039.md) | [4.0 d](/filings/0001628280-26-019865.md) | [0.0](/filings/0001628280-26-035236.md) | [0.0](/filings/0001628280-26-056821.md) |
| Net income | $m | [33.3](/filings/0001844452-25-000023.md) | [8.4 d](/filings/0001844452-25-000023.md) | [(97.5)](/filings/0001844452-25-000043.md) | [18.7](/filings/0001844452-25-000054.md) | [(55.4)](/filings/0001628280-25-052039.md) | [(149) d](/filings/0001628280-26-019865.md) | [(11.4)](/filings/0001628280-26-035236.md) | [(25.2)](/filings/0001628280-26-056821.md) | [(6.8)](/filings/0001628280-25-052039.md) | [(39.9) d](/filings/0001628280-26-019865.md) | [(37.4)](/filings/0001628280-26-035236.md) | [(46.4)](/filings/0001628280-26-056821.md) |
| Diluted EPS | $ per share | [1.27](/filings/0001844452-25-000023.md) | not reported | [(2.68)](/filings/0001844452-25-000043.md) | [0.30](/filings/0001844452-25-000054.md) | [(0.83)](/filings/0001628280-25-052039.md) | not reported | [(0.11)](/filings/0001628280-26-035236.md) | [(0.22)](/filings/0001628280-26-056821.md) | [(0.06)](/filings/0001628280-25-052039.md) | not reported | [(0.25)](/filings/0001628280-26-035236.md) | [(0.29)](/filings/0001628280-26-056821.md) |
| Basic EPS | $ per share | [1.87](/filings/0001844452-25-000023.md) | not reported | [(2.68)](/filings/0001844452-25-000043.md) | [0.34](/filings/0001844452-25-000054.md) | [(0.83)](/filings/0001628280-25-052039.md) | not reported | [(0.11)](/filings/0001628280-26-035236.md) | [(0.22)](/filings/0001628280-26-056821.md) | [(0.06)](/filings/0001628280-25-052039.md) | not reported | [(0.25)](/filings/0001628280-26-035236.md) | [(0.29)](/filings/0001628280-26-056821.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [40.7](/filings/0001844452-24-000132.md) | [4.5](/filings/0001844452-25-000023.md) | [55.2](/filings/0001844452-25-000043.md) | [31.6](/filings/0001844452-25-000054.md) | [89.6](/filings/0001628280-25-052039.md) | [208](/filings/0001628280-26-019865.md) | [373](/filings/0001628280-26-035236.md) | [345](/filings/0001628280-26-056821.md) | [622](/filings/0001628280-25-052039.md) | [583](/filings/0001628280-26-056821.md) | [232](/filings/0001628280-26-035236.md) | [367](/filings/0001628280-26-056821.md) |
| Current assets | $m | [48.9](/filings/0001844452-23-000065.md) | [31.6](/filings/0001844452-25-000023.md) | [116](/filings/0001844452-24-000070.md) | [83.1](/filings/0001844452-24-000094.md) | [168](/filings/0001844452-24-000132.md) | [293](/filings/0001628280-26-019865.md) | [431](/filings/0001844452-25-000043.md) | [397](/filings/0001844452-25-000054.md) | [666](/filings/0001628280-25-052039.md) | [619](/filings/0001628280-26-056821.md) | [505](/filings/0001628280-26-035236.md) | [663](/filings/0001628280-26-056821.md) |
| Total assets | $m | [103](/filings/0001844452-23-000065.md) | [85.9](/filings/0001844452-25-000023.md) | [171](/filings/0001844452-24-000070.md) | [140](/filings/0001844452-24-000094.md) | [225](/filings/0001844452-24-000132.md) | [355](/filings/0001628280-26-019865.md) | [500](/filings/0001844452-25-000043.md) | [476](/filings/0001844452-25-000054.md) | [754](/filings/0001628280-25-052039.md) | [757](/filings/0001628280-26-056821.md) | [1,718](/filings/0001628280-26-035236.md) | [1,887](/filings/0001628280-26-056821.md) |
| Current liabilities | $m | [97.7](/filings/0001844452-24-000132.md) | [81.5](/filings/0001844452-25-000023.md) | [105](/filings/0001844452-24-000070.md) | [85.0](/filings/0001844452-24-000094.md) | [95.3](/filings/0001844452-24-000132.md) | [98.8](/filings/0001628280-26-019865.md) | [98.1](/filings/0001844452-25-000043.md) | [107](/filings/0001844452-25-000054.md) | [106](/filings/0001628280-25-052039.md) | [125](/filings/0001628280-26-056821.md) | [415](/filings/0001628280-26-035236.md) | [400](/filings/0001628280-26-056821.md) |
| Total liabilities | $m | [159](/filings/0001844452-24-000132.md) | [137](/filings/0001844452-25-000023.md) | [215](/filings/0001844452-24-000070.md) | [150](/filings/0001844452-24-000094.md) | [229](/filings/0001844452-24-000132.md) | [351](/filings/0001628280-26-019865.md) | [172](/filings/0001844452-25-000043.md) | [185](/filings/0001844452-25-000054.md) | [510](/filings/0001628280-25-052039.md) | [553](/filings/0001628280-26-056821.md) | [987](/filings/0001628280-26-035236.md) | [976](/filings/0001628280-26-056821.md) |
| Long-term debt | $m | [0.0](/filings/0001844452-23-000065.md) | [0.0](/filings/0001844452-25-000023.md) | [0.0](/filings/0001844452-24-000070.md) | [0.0](/filings/0001844452-24-000094.md) | [0.0](/filings/0001844452-24-000132.md) | [0.0](/filings/0001628280-26-019865.md) | not reported | not reported | [335](/filings/0001628280-25-052039.md) | [335](/filings/0001628280-26-056821.md) | [336](/filings/0001628280-26-035236.md) | [336](/filings/0001628280-26-056821.md) |
| Current portion of debt | $m | [20.0](/filings/0001844452-23-000065.md) | [8.0](/filings/0001844452-25-000023.md) | [8.0](/filings/0001844452-24-000070.md) | [3.0](/filings/0001844452-24-000094.md) | [0.0](/filings/0001844452-24-000132.md) | [0.0](/filings/0001844452-25-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(343)](/filings/0001844452-24-000132.md) | [(261)](/filings/0001844452-25-000023.md) | [(494)](/filings/0001844452-24-000070.md) | [(235)](/filings/0001844452-24-000094.md) | [(497)](/filings/0001844452-24-000132.md) | [(1,009)](/filings/0001628280-26-019865.md) | [(137)](/filings/0001844452-25-000043.md) | [(381)](/filings/0001844452-25-000054.md) | [(404)](/filings/0001628280-25-052039.md) | [(755)](/filings/0001628280-26-056821.md) | [(334)](/filings/0001628280-26-035236.md) | [(291)](/filings/0001628280-26-056821.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.2) d](/filings/0001844452-24-000132.md) | [(22.3) d](/filings/0001844452-25-000023.md) | [(6.4)](/filings/0001844452-25-000043.md) | [(31.3) d](/filings/0001844452-25-000054.md) | [(17.9) d](/filings/0001628280-25-052039.md) | [(2.0) d](/filings/0001628280-26-019865.md) | [19.4](/filings/0001628280-26-035236.md) | [(19.3) d](/filings/0001628280-26-056821.md) | [(7.2) d](/filings/0001628280-25-052039.md) | [(7.3) d](/filings/0001628280-26-019865.md) | [(54.8)](/filings/0001628280-26-035236.md) | [(57.1) d](/filings/0001628280-26-056821.md) |
| Capital expenditure | $m | [7.5 d](/filings/0001844452-24-000132.md) | [2.2 d](/filings/0001844452-25-000023.md) | [1.6](/filings/0001844452-25-000043.md) | [2.2 d](/filings/0001844452-25-000054.md) | [1.4 d](/filings/0001628280-25-052039.md) | [4.9 d](/filings/0001628280-26-019865.md) | [6.1](/filings/0001628280-26-035236.md) | [8.1 d](/filings/0001628280-26-056821.md) | [11.8 d](/filings/0001628280-25-052039.md) | [15.6 d](/filings/0001628280-26-019865.md) | [9.9](/filings/0001628280-26-035236.md) | [24.1 d](/filings/0001628280-26-056821.md) |
| Dividends paid | $m | [3.7 d](/filings/0001844452-24-000132.md) | [0.0 d](/filings/0001844452-25-000023.md) | not reported | not reported | [0.0 d](/filings/0001844452-24-000132.md) | [0.0 d](/filings/0001844452-25-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001844452-25-000043.md) | [0.0 d](/filings/0001844452-25-000054.md) | [0.0 d](/filings/0001628280-25-052039.md) | [0.0 d](/filings/0001628280-26-019865.md) | [20.7](/filings/0001628280-26-035236.md) | [0.0 d](/filings/0001628280-26-056821.md) | [0.0 d](/filings/0001628280-25-052039.md) | [0.0 d](/filings/0001628280-26-019865.md) | [0.0](/filings/0001628280-26-035236.md) | [0.0 d](/filings/0001628280-26-056821.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.2](/filings/0001844452-24-000070.md) | [19.4](/filings/0001844452-24-000094.md) | [26.1](/filings/0001844452-24-000132.md) | [36.6](/filings/0001844452-25-000043.md) | [62.3](/filings/0001844452-25-000054.md) | [67.1](/filings/0001628280-25-052039.md) | [107](/filings/0001628280-26-035236.md) | [117](/filings/0001628280-26-056821.md) | [118](/filings/0001628280-25-052039.md) | [148](/filings/0001628280-26-035236.md) | [162](/filings/0001628280-26-056821.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 84,172,557 at 2023-03-29, from the cover of the [10-K filed 2023-03-31](/filings/0001213900-23-024857.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.